Warby Parker Inc. WRBY
We take great care to ensure that the data presented and summarized in this overview for Warby Parker Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding WRBY
View all-
Vanguard Group Inc Valley Forge, PA10.3MShares$252 Million0.0% of portfolio
-
Durable Capital Partners LP Bethesda, MD9.6MShares$234 Million1.65% of portfolio
-
Black Rock Inc. New York, NY7.25MShares$177 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.85MShares$69.6 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C32.24MShares$54.7 Million0.06% of portfolio
-
Vaughan Nelson Investment Management, L.P.2.22MShares$54.1 Million0.47% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$53.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.16MShares$52.6 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL2.11MShares$51.5 Million0.01% of portfolio
-
Jennison Associates LLC1.99MShares$48.6 Million0.03% of portfolio
Latest Institutional Activity in WRBY
Top Purchases
Top Sells
About WRBY
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Insider Transactions at WRBY
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-63.82%
|
$1,250,000
$25.11 P/Share
|
|
Aug 13
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
50,000
+38.96%
|
-
|
|
Aug 11
2025
|
Teresa Briggs Director |
SELL
Open market or private sale
|
Direct |
6,000
-11.79%
|
$138,000
$23.56 P/Share
|
|
Jul 21
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
49,600
-63.63%
|
$1,190,400
$24.21 P/Share
|
|
Jul 21
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
49,600
+38.89%
|
-
|
|
Jul 21
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
74,500
-72.35%
|
$1,788,000
$24.27 P/Share
|
|
Jul 21
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
74,500
+41.98%
|
-
|
|
Jul 18
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
400
-1.39%
|
$9,600
$24.01 P/Share
|
|
Jul 18
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
400
+1.37%
|
-
|
|
Jul 18
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
500
-1.73%
|
$12,000
$24.01 P/Share
|
|
Jul 18
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
500
+1.7%
|
-
|
|
Jul 01
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-63.71%
|
$1,100,000
$22.04 P/Share
|
|
Jul 01
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
50,000
+38.92%
|
-
|
|
Jun 10
2025
|
Youngme E Moon Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,020
+15.43%
|
-
|
|
Jun 10
2025
|
Jeffrey Jacob Raider Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,020
+2.31%
|
-
|
|
Jun 10
2025
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,362
+14.72%
|
-
|
|
Jun 10
2025
|
Teresa Briggs Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,020
+19.11%
|
-
|
|
Jun 10
2025
|
Bradley E Singer Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,026
+33.5%
|
-
|
|
Jun 10
2025
|
Andrew Hunt Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,026
+0.82%
|
-
|
|
Jun 03
2025
|
Steven Clive Miller Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,692
-7.04%
|
$350,532
$21.48 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 148K shares |
|---|---|
| Conversion of derivative security | 2.31M shares |
| Exercise of conversion of derivative security | 137K shares |
| Open market or private sale | 2.41M shares |
|---|---|
| Payment of exercise price or tax liability | 59.6K shares |
| Bona fide gift | 1.52M shares |
| Other acquisition or disposition | 5.66M shares |